Abstracts are due soon for mass spec meeting in August

If you intend to attend and present your work at the 13th International Symposium on Mass Spectrometry in the Health and Life Sciences in San Francisco in August, you have only a few weeks left to submit your abstract.

The symposium is being headed up by A.L. Burlingame of the University of California, San Francisco, Steven A. Carr of The Broad Institute of MIT and Harvard, and Bernhard Küster of the Technical University Munich, Germany. Burlingame is editor-in-chief, Carr is deputy editor and Kuster is an associate editor for the ASBMB journal Molecular & Cellular Proteomics.

The program kicks off on Sunday, Aug. 18, with a minisymposium on data-independent analysis, organized by Robert Chalkley of UCSF (MCP’s data management editor) and Hannes Röst of the Donnelly Centre for Cellular and Biomolecular Research at the University of Toronto.

The main symposium begins on Monday, Aug. 19, and continues through Tuesday, Aug. 20. Here are some program highlights:

Plenary lecturers

Technology talks

  • Chemoproteomics
  • Development, use, application of novel TIMS-Tof system
  • A proteomics view of mTOR signaling in humans
  • Interactomics, chromatin proteomics
  • Protein interaction networks controlling gene expression programs and beyond
  • Protein-RNA interactions

Degradomics and protein dynamics talks

  • Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis
  • Understanding effects of protein degrader drugs via targeted assays: from bench to bedside
  • New Ub profiling approaches and applications

Biological applications talks

  • Acetylation biology
  • Large-scale analysis of human iPS cells
  • Modulating nerve growth through RNA-protein interactions

Immuno-oncology talks

  • Mitochondria as a source of antigen presentation
  • Systematic profiling of HLA class I immunopeptidome improves neoantigen binding prediction
  • sMORFs/RiboSeq for neoantigens
  • Noncoding regions are the main source of targetable tumor-specific antigens

Translational proteomics talks

  • Non-MS-based techniques for proteomic profiling of large human cohorts: Trust … but verify
  • Ovarian cancer EDRN and/or BC prospective
  • Endometrial cancer

Protein complexes talks

  • The growing molecular complexity of ribosome biology
  • Cancer proteomics
  • Characterization of complexes and organelles

Submit your abstract by July 7.

Categories: Uncategorized

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.